SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: shdu who wrote (79)8/21/1997 2:30:00 PM
From: Charles Hill   of 656
 
<<Immunex is also doing a phase III trial that compares Enbrel vs. methotrexate and placebo. The company is still recuiting patients for this phase III trial. I don't really understand why they are doing several phase III trials one after another. Clinical trials have high costs.>>

I believe that the different trials are for different indications. BTW --- I heard that there is an analysts meeting at Immunex this week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News